Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0

Posted on By

Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0

SOP for Addressing Non-Conformance in Aerosol Manufacturing

Department Aerosol
SOP No. SOP/Aerosol/174/2025
Supersedes SOP/Aerosol/174/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a structured process for identifying, documenting, investigating, and addressing non-conformances in aerosol manufacturing. The goal is to ensure product quality, regulatory compliance, and continuous improvement.

2. Scope

This SOP applies to all manufacturing operations in the aerosol department, including raw material handling, formulation, filling, crimping, packaging, and final product inspection.

3. Responsibilities

  • Production Team: Responsible for identifying and reporting non-conformances during manufacturing.
  • Quality Assurance (QA) Team: Responsible for investigating non-conformances and approving corrective actions.
  • Engineering Team: Responsible for resolving equipment-related non-conformances.
  • Regulatory Affairs Team: Responsible for ensuring that non-conformance handling aligns with regulatory requirements.

4. Accountability

The QA Manager is accountable for ensuring that all non-conformances are documented, investigated, and corrective/preventive actions are implemented.

See also  Aerosol: SOP for Managing Expiry and Retest Dates for Raw Materials - V 2.0

5. Procedure

5.1. Identifying Non-Conformance

  1. Non-conformances can include:
    • Product defects (e.g., incorrect fill volume, valve malfunction).
    • Process deviations (e.g., incorrect mixing time, temperature variations).
    • Equipment failures (e.g., crimping defects, pressure inconsistencies).
    • Packaging errors (e.g., mislabeling, seal integrity issues).
  2. All non-conformances must be recorded in the Non-Conformance Log (Annexure-1).

5.2. Immediate Action

  1. Quarantine the affected batch to prevent further processing.
  2. Notify the QA team and document the incident in the Immediate
Action Log (Annexure-2).
  • Identify potential safety risks and implement containment measures.
  • 5.3. Investigation and Root Cause Analysis

    1. The QA team will conduct a preliminary investigation within 24 hours.
    2. Root cause analysis should use appropriate tools:
      • 5 Whys Analysis
      • Fishbone Diagram
      • Failure Mode and Effects Analysis (FMEA)
    3. Investigation findings should be documented in the Investigation Report (Annexure-3).

    5.4. Corrective and Preventive Actions (CAPA)

    1. Based on the investigation, corrective and preventive actions should be implemented.
    2. All CAPA activities must be recorded in the CAPA Log (Annexure-4).
    3. Corrective actions may include:
      • Process adjustments.
      • Equipment maintenance or recalibration.
      • Additional training for personnel.

    5.5. Verification and Closure

    1. The QA team will verify that corrective actions have been effectively implemented.
    2. If successful, the non-conformance case is closed, and the details are recorded in the Non-Conformance Closure Log (Annexure-5).

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • FMEA: Failure Mode and Effects Analysis
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Non-Conformance Log (Annexure-1)
    2. Immediate Action Log (Annexure-2)
    3. Investigation Report (Annexure-3)
    4. CAPA Log (Annexure-4)
    5. Non-Conformance Closure Log (Annexure-5)

    8. References

    • Good Manufacturing Practice (GMP) Guidelines
    • ISO 9001 – Quality Management Systems
    • FDA Guidance on Non-Conformance Management

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Non-Conformance Log

    NC ID Issue Description Reported By Date Status
    NC-001 Incorrect fill volume Rajesh Patel 06/02/2025 Open

    Annexure-2: Immediate Action Log

    NC ID Action Taken Performed By Date
    NC-001 Batch quarantined Amit Sharma 06/02/2025

    Annexure-3: Investigation Report

    NC ID Root Cause Investigated By Date
    NC-001 Valve malfunction Ramesh Kumar 07/02/2025
    NC-002 Incorrect propellant ratio Anita Sharma 08/02/2025

    Annexure-4: CAPA Log

    NC ID Corrective Action Preventive Action Responsible Person Date
    NC-001 Replaced faulty valve Regular valve inspection Amit Sharma 08/02/2025
    NC-002 Adjusted propellant ratio Automated calibration system Rahul Mehta 09/02/2025

    Annexure-5: Non-Conformance Closure Log

    NC ID Verification Date Verified By Closure Status
    NC-001 10/02/2025 Sunil Verma Closed
    NC-002 11/02/2025 Priya Sharma Closed

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
    01/01/2025 V 2.0 Updated CAPA and verification process GMP Compliance Anjali Sharma
    See also  Aerosol: SOP for Review of Cleaning Validation Data - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Biosimilars: SOP for Sampling During Night Shifts – V 2.0
    Next Post: Creams: SOP for Deviations Handling in Cream Production – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version